The value of the nonprofit tax exemption is worth tens of billions to hospitals. But what are we getting back in exchange for this hefty tax break? Watch the launch video for a discussion of community benefit standards, hospital billing practices, and fair share spending with health policy experts.
More
Lown calculated a total fair share deficit of $17 billion in 2018, the latest year for which tax forms were available. Individual hospital deficits ranged from a few thousand dollars to $261 million at Cleveland Clinic's main campus.
"What we're finding is, based on the dollar benefit of the non-profit status, there are a lot of hospitals that really aren't meeting that social contract, if you will," said Dr. Vikas Saini, president of the Lown Institute, a nonpartisan think tank focused on healthcare cost, quality and equity issues.
More
Though all nonprofit hospitals enjoy big tax breaks, many fail to make commensurate investments in community health, according to a new analysis from the Lown Institute. The Institute today released Community Benefit findings from its 2021 Hospitals Index, that show nonprofit hospitals collectively failed to invest nearly $17 billion in their communities.
More
This cross-sectional study uses data from the Centers for Medicare & Medicaid Services to assess whether higher-performing hospitals are more likely to advertise their services directly to consumers.
More
Since January, hospitals were supposed to be disclosing true prices for their services, as a way to empower patients to shop around. Turns out, compliance is spotty and the data can be hard to find.
More
The Biden administration released the first part of regulations to implement a law that bans surprise medical bills, outlining what types of charges will be outlawed starting in 2022.
More
Although most well-known patient organizations have important missions and provide invaluable services to patients, many appear unable or unwilling to take positions on consumer issues such as lowering prescription drug prices that might anger their drug corporation funders.
More
Plans like United Healthcare say it’s necessary to contain health care costs. Experts say it’s the wrong approach.
More
How New Hospital Transparency Regulations Fall Short
More
Consumers may think they’re safer or more “natural” than pharmaceuticals, but multiple studies show they are sometimes adulterated with medicines and unknown additives.
More
When Aduhelm’s prospects appeared dead, Biogen mounted a secret campaign to resurrect the drug and convince the FDA to approve it.
More
Nearly 70% of all U.S. physicians are now employed by hospitals or corporations.
More
Two new studies analyzing hospital price transparency find that fewer than 25% of hospitals are complying with the new CMS rule.
More
A Q&A with physician and former FDA advisor Aaron Kesselheim on why he resigned to protest the approval of a new Alzheimer’s drug — and the reforms necessary to prevent it from happening again.
More
The 1,000 new residency slots funded by the American Rescue Plan should go first to hospitals in rural, underserved, and tribal areas.
More
Across the street from the Buckingham Palace Garden and an ocean away from its Ohio headquarters, Cleveland Clinic is making a nearly $1 billion bet that Europeans will embrace a hospital run by one of America’s marquee health systems.
More
"Efforts for value-based reforms may be hampered by a lack of cost-effectiveness data," the authors write.
More
Federal officials say that some of the money changing hands has corrupted doctors and endangered patients.
More
It was not due to higher volumes of filled prescriptions.
More
The Biden administration has a chance to help curb drug costs in naming a new patent office director, some experts say.
More